First-line afatinib for the treatment of EGFR mutation-positive non-small-cell lung cancer in the 'real-world' clinical setting.

Yoshihisa Kobayashi, Yosuke Togashi, Yasushi Yatabe, Hiroshi Mizuuchi, Park Jangchul, Chiaki Kondo, Masaki Shimoji, Katsuaki Sato, Kenichi Suda, Kenji Tomizawa, Toshiki Takemoto, Toyoaki Hida, Kazuto Nishio, Tetsuya Mitsudomi, EGFR Exon 18 Mutations in Lung Cancer: Molecular Predictors of Augmented Sensitivity to Afatinib or Neratinib as Compared with First- or Third-Generation TKIs Clinical Cancer Research. ,vol. 21, pp. 5305- 5313 ,(2015) , 10.1158/1078-0432.CCR-15-1046

L. V. Sequist, B. A. Waltman, D. Dias-Santagata, S. Digumarthy, A. B. Turke, P. Fidias, K. Bergethon, A. T. Shaw, S. Gettinger, A. K. Cosper, S. Akhavanfard, R. S. Heist, J. Temel, J. G. Christensen, J. C. Wain, T. J. Lynch, K. Vernovsky, E. J. Mark, M. Lanuti, A. J. Iafrate, M. Mino-Kenudson, J. A. Engelman, Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors Science Translational Medicine. ,vol. 3, ,(2011) , 10.1126/SCITRANSLMED.3002003

Barbara Melosky, Vera Hirsh, Management of Common Toxicities in Metastatic NSCLC Related to Anti-Lung Cancer Therapies with EGFR–TKIs Frontiers in Oncology. ,vol. 4, pp. 238- 238 ,(2014) , 10.3389/FONC.2014.00238

Maria E. Arcila, Geoffrey R. Oxnard, Khedoudja Nafa, Gregory J. Riely, Stephen B. Solomon, Maureen F. Zakowski, Mark G. Kris, William Pao, Vincent A. Miller, Marc Ladanyi, Rebiopsy of Lung Cancer Patients with Acquired Resistance to EGFR Inhibitors and Enhanced Detection of the T790M Mutation Using a Locked Nucleic Acid-Based Assay Clinical Cancer Research. ,vol. 17, pp. 1169- 1180 ,(2011) , 10.1158/1078-0432.CCR-10-2277

Nicolas Roche, Helen Reddel, Richard Martin, Guy Brusselle, Alberto Papi, Mike Thomas, Dirjke Postma, Vicky Thomas, Cynthia Rand, Alison Chisholm, David Price, Respiratory Effectiveness Group, None, Quality standards for real-world research. Focus on observational database studies of comparative effectiveness Annals of the American Thoracic Society. ,vol. 11, ,(2014) , 10.1513/ANNALSATS.201309-300RM

Satoshi Watanabe, Yuji Minegishi, Hirohisa Yoshizawa, Makoto Maemondo, Akira Inoue, Shunichi Sugawara, Hiroshi Isobe, Masao Harada, Yoshiki Ishii, Akihiko Gemma, Koichi Hagiwara, Kunihiko Kobayashi, Effectiveness of Gefitinib against Non–Small-Cell Lung Cancer with the Uncommon EGFR Mutations G719X and L861Q Journal of Thoracic Oncology. ,vol. 9, pp. 189- 194 ,(2014) , 10.1097/JTO.0000000000000048

Yin-Duo Zeng, Li Zhang, Hai Liao, Ying Liang, Fei Xu, Jun-Ling Liu, Xiao-Xiao Dinglin, Li-Kun Chen, Gefitinib alone or with concomitant whole brain radiotherapy for patients with brain metastasis from non-small-cell lung cancer: a retrospective study. Asian Pacific Journal of Cancer Prevention. ,vol. 13, pp. 909- 914 ,(2012) , 10.7314/APJCP.2012.13.3.909

Pasi A. Jänne, James Chih-Hsin Yang, Dong-Wan Kim, David Planchard, Yuichiro Ohe, Suresh S. Ramalingam, Myung-Ju Ahn, Sang-We Kim, Wu-Chou Su, Leora Horn, Daniel Haggstrom, Enriqueta Felip, Joo-Hang Kim, Paul Frewer, Mireille Cantarini, Kathryn H. Brown, Paul A. Dickinson, Serban Ghiorghiu, Malcolm Ranson, AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer The New England Journal of Medicine. ,vol. 372, pp. 1689- 1699 ,(2015) , 10.1056/NEJMOA1411817

Vanita Noronha, Amit Joshi, Anant Gokarn, Vibhor Sharma, Vijay Patil, Amit Janu, Nilendu Purandare, Anuradha Chougule, Nirmala Jambhekar, Kumar Prabhash, The Importance of Brain Metastasis in EGFR Mutation Positive NSCLC Patients Chemotherapy Research and Practice. ,vol. 2014, pp. 856156- 856156 ,(2014) , 10.1155/2014/856156

Lecia V. Sequist, James Chih-Hsin Yang, Nobuyuki Yamamoto, Kenneth O'Byrne, Vera Hirsh, Tony Mok, Sarayut Lucien Geater, Sergey Orlov, Chun-Ming Tsai, Michael Boyer, Wu-Chou Su, Jaafar Bennouna, Terufumi Kato, Vera Gorbunova, Ki Hyeong Lee, Riyaz Shah, Dan Massey, Victoria Zazulina, Mehdi Shahidi, Martin Schuler, Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations Journal of Clinical Oncology. ,vol. 31, pp. 3327- 3334 ,(2013) , 10.1200/JCO.2012.44.2806